Babies exposed to HIV should get antibiotic -- U.N.

Key points
- Babies of HIV-infected mothers should be given an inexpensive antibiotic to prevent infections and prolong their lives, United Nations aid agencies said on Tuesday.
- Children's Fund (UNICEF), UNAIDS and World Health Organization (WHO) follows a report in The Lancet medical journal last Friday that a daily dose of the drug co-trimoxazole nearly halved the death rate in children.
- Trials involving children aged one to 14 years in Zambia lasted 19 months, and the drug was deemed a success.
- The U.N. agencies, in their joint advice to health ministries and aid workers, said that co-trimoxazole was a "crucial potentially life-saving intervention that should be given to all HIV-exposed children born to HIV-infected mothers."
Babies of HIV-infected mothers should be given an inexpensive antibiotic to prevent infections and prolong their lives, United Nations aid agencies said on Tuesday.
The recommendation by the U.N. Children's Fund (UNICEF), UNAIDS and World Health Organization (WHO) follows a report in The Lancet medical journal last Friday that a daily dose of the drug co-trimoxazole nearly halved the death rate in children.
Trials involving children aged one to 14 years in Zambia lasted 19 months, and the drug was deemed a success.
The U.N. agencies, in their joint advice to health ministries and aid workers, said that co-trimoxazole was a "crucial potentially life-saving intervention that should be given to all HIV-exposed children born to HIV-infected mothers."
It should be offered as "part of a basic package of care to reduce morbidity and mortality," the agencies said.
Treatment should begin in children from four to six weeks of age and should continue until HIV infection has been definitively ruled out and the mother is no longer breast-feeding, they added.
It should be used before children require antiretroviral drugs "because it may even postpone the time at which antiretroviral therapy needs to be started," the joint statement said.
Jim Kim, director of WHO's HIV department, told Reuters: "This is an important piece of information which we hope to get out so that ministries of health change practices very quickly. We'd be happy if it is implemented in the next six months."
The drug is already used to both prevent and treat a form of pneumonia that commonly kills both HIV-infected adults and children, according to WHO.
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Infections, HIV & STIs →
NewsU.S. panel says Optimer's antibiotic effective
Optimer Pharmaceuticals Inc's experimental antibiotic is safe and effective in treating a bacterial infection that causes diarrhea, a U.S. advisory panel said on Tuesday. The advisory panel of 13 independent experts…
6 April 2011
NewsStudy suggests why HIV-uninfected babies of mothers with HIV might be more prone to infections
Babies whose mothers have HIV, but who are not HIV-infected themselves, are born with lower levels of specific proteins in their blood called antibodies, which fight infection, compared with babies not exposed to HIV, a…
10 February 2011
NewsPharmaceutical conservation key to slowing rise of antibiotic-resistant infections
The United States must focus on conserving the use of antibacterial drugs, or face a public health crisis from rapidly rising rates of antibiotic-resistant infections, according to an analysis out today. Evidence…


